Baxter
Working at Baxter
Baxter has renewed its focus on science and technology and enhanced its culture of innovation. In fact, science shapes the future of Baxter. The company's commitment to research and development proves that point, increasing by 24 percent from 2006 to 2007 and reaching $760 million.
Company Overview
Baxter is a developer, manufacturer and marketer of products used to treat complex medical conditions. The company applies its unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that save and sustain the lives of patients with hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other chronic and acute conditions.
These products are developed through Baxter's three main businesses: BioScience, Medication Delivery, and Renal.
Business Overviews
BioScience: The BioScience business manufactures recombinant and plasma-based proteins used to treat hemophilia and other bleeding disorders, plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock and other chronic and acute blood-related conditions, biosurgery and other products for regenerative medicine, such as proteins used in hemostasis, wound-sealing and tissue-regeneration, and vaccines.
Medication Delivery: The Medication Delivery business manufactures products used to deliver fluids and drugs to patients. These include intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products and infusion pumps, and inhalation anesthetics as well as products and services related to drug formulation and packaging technologies.
Renal: The Renal business manufactures products to treat end-stage renal disease, or irreversible kidney failure. The business manufactures peritoneal dialysis (PD) solutions and other products for PD, a home-based dialysis therapy, and also distributes products for hemodialysis, which is generally conducted in a hospital or clinic.
Industry Leadership
Baxter is a leader in most of the markets it serves. We are the largest maker of IV solutions and other products that deliver fluids and drugs to patients. We are the leading provider of recombinant clotting factor for hemophilia. We are the largest provider of dialysis solutions for home dialysis. Baxter's expertise in medical devices, pharmaceuticals and biotechnology makes the company unique in the healthcare industry.
A Culture Grounded in Shared Values
Baxter's culture is grounded in a set of Shared Values. These include: a passion to innovate, personal accountability for results, integrity, eagerness to learn and continuously improve, uncompromising dedication to quality, relentless focus on rapid and disciplined action, and respect for the diverse contributions of all.
Commitment to Innovation and R&D
Baxter's commitment to research and development reached $760 million in 2007. This substantial investment is used to support the existing product portfolio and movement into closely related therapeutic areas as well as new exciting opportunities.
Commitment to Sustainability
Baxter views sustainability as a long-term approach to balancing its business priorities with social, economic and environmental responsibilities. Areas of sustainability include ethics and compliance, support for employees, environment, health and safety, and community support.
